As well as yesterday’s announcement of a collaboration with Solarvest BioEnergy Inc to research using its algal expression technology to develop pharmaceutical-grade cannabinoids, FSD Pharma (CSE.HUGE) is also involved with Aura Health Inc. (CSE:BUZZ). This collaboration will give FSD Pharma a window into the medical marijuana market in Germany and, eventually, the EU generally.
CFN Media provides a useful summary of FSD’s collaborations and investments in a news release and an article published today.
The article is excellent as it lays out how strategic investments in the Cannabis sector are paying off for FSD Pharma.